Acetyl-CoA carboxylase was purified 16-fold from platelet extracts, and this partially purified enzyme was compared to enzyme from rat liver. The two enzymes were similar with respect to requirements, substrate affinities, pH profile of activity, inhibition by malonylCoA, and aggregation in the presence of citrate. Thus, while fatty acid synthesis may serve a different function in platelets than in liver, the properties of acetyl-CoA carboxylase from these tissues are alike.
INTRODUCTION
The mechanism of de novo fatty acid synthesis in mammalian systems is described by the following reactions: (1) . Thus, in the presence of citrate the enzyme is converted from an inactive-disaggregated form to an active-aggregated enzyme. All of the subsequent reactions of fatty acid synthesis in mammals are catalyzed by a "soluble" multienzyme complex which is designated fatty acid synthetase (1) .
Previous studies have demonstrated that neither mature erythrocytes (2) nor leukocytes (3) are capable of de novo fatty acid synthesis because they lack acetylCoA carboxylase activity, although they retain fatty acid synthetase activity. Further studies suggested that a precursor hematopoietic cell may have the capacity to synthesize fatty acids and that this capability is lost as the cells mature. Thus, blast cells from leukemic patients were found to have low levels of acetyl-CoA carboxylase (3) , and recently hemolysates of reticulocyte-rich blood from rabbits and humans have been found to contain acetyl-CoA carboxylase activity (4) .
In contrast to erythrocytes and leukocytes, platelets contain the enzymes of fatty acid synthesis including METHODS Blood samples were collected in plastic syringes or bags from healthy volunteers and from patients without regard to diet. The blood was anticoagulated with ACD 1; total and differential white blood cell counts, hemoglobin concentration, hematocrit value, and enumeration of erythrocytes, reticulocytes, and platelets were performed on all samples by standard techniques. All studies were carried out with either plastic or siliconized equipment, and samples were processed immediately after blood samples were drawn.
Fatty acid synthesis in platelets. 50-ml samples of blood were mixed with 5 ml of ACD and were then centrifuged at 90 g for 25 min at 40C. All subsequent procedures were carried out at 4VC. The platelet-rich supernatant plasma was removed and was centrifuged at 3000 g for 10 min. The platelet-poor plasma supernatant solution was removed from the platelet pellet and mixed with the erythrocyte pellet obtained from the first centrifugation. This mixture was then centrifuged at 90 g for 25 min, and the resulting second platelet-rich plasma supernatant solution was added to the platelet pellet and was then centrifuged at 3000 g for 10 min. This second extraction resulted in an increase in the total platelet recovery from 50 to 85%o. The final platelet pellet was then suspended in plasma and transferred into a 5 X 50 mm plastic tube and, after centrifugation at 3000 g for 10 min, the supernatant plasma was discarded and the platelet pellet was suspended in 1 ml of an isotonic solution containing 0.10 M potassium phosphate, pH 7.5, 0.001 M ethylenediaminetetraacetate (EDTA), 0.01 Ai 2-mercaptoethanol, and 0.25 M sucrose. The 2-mercaptoethanol was added to stabilize the enzymes of fatty acid synthesis, since many of these enzymes are sensitive to oxidation of key sulfhydryl groups (1). This suspension was then treated with ultrasound in a Biosonik II 2 sonifier with a microprobe at 10% intensity for 10 sec. Longer periods of sonication failed to release further protein. The sonicate was then centrifuged at 49,000 g for 1 hr, and the resulting supernatant solution was used to determine acetyl-CoA carboxylase and fatty acid synthetase activity. Similar results were also obtained with supernatant solutions after centrifugation of the sonicate at 105,000 g for 1 hr. The recovery of platelets by this procedure was 85 +10%, and the contamination of the platelet-rich plasma with leukocytes and erythrocytes was consistently less than 1/5000 platelets.
For preparative studies platelets were collected in ACD from freshly drawn blood and were pooled according to blood type and isolated by centrifugation as described above. The platelets from 10 U of blood were pooled and suspended in 15 ml of the same buffer used with small batches of platelets. While the batches of platelets used in the experiments described below were all processed immediately after collection, in other experiments it was shown that platelet pellets could be frozen in liquid nitrogen overnight without loss of enzyme activity upon subsequent study. These sus-1ACD, acid citrate dextrose, USP formula A. 2 Bronwill Scientific, Rochester, N. Y.
pensions were sonified for 10 sec at 70% intensity in a Biosonik II sonifier with the standard probe. The conditions of sonication used resulted in complete platelet rupture based upon the release of soluble protein. Sonication at higher intensity resulted in some loss of enzyme activity. Fatty acid synthetase assay. Fatty acid synthetase activity was measured on Sephadex-treated extracts as described previously with malonyl-CoA-2-J4C (1 iuc/,Amole) (3) . This assay was linear with time for 1 hr and was proportional to enzyme concentration.
Purification of acetyl-CoA carboxylase. Acetyl-CoA carboxylase was purified as described previously (4) through the second ammonium sulfate step. In this manner enzyme was obtained which was 16.3-fold purified over the crude Sephadex-treated supernatant solution (Table I ). The first ammonium sulfate step was performed at the time the platelets were collected in batches of 10 U, and the 15-30% ammonium sulfate fraction was stored in liquid nitrogen until five batches were accumulated which were then pooled for the subsequent purification shown in Table I . The yield obtained in the initial ammonium sulfate step averaged about 40%, so that the over-all yield of the 16.3-fold purified enzyme was about 11%o. Acetyl-CoA carboxylase from platelets is a very unstable enzyme as has been found in other tissues. The enzyme was stable however when frozen in liquid nitrogen and stored at -140°F. This partially purified enzyme was used to study the properties of acetyl-CoA carboxylase from platelets.
Fatty acid synthesis in human liver. Specimens of histologically normal human liver were obtained from surgical biopsy specimens. The samples were immediately minced in cold buffer, and homogenates were prepared as described previously for rat liver (5) and assayed for fatty acid synthetase and acetyl-CoA carboxylase activity.
Gas-liquid chromatography was performed as described previously (3) . Methyl esters were formed by heating the free fatty acids formed by platelet fatty acid synthetase in 2%o methanolic sulfuric acid at 70°C for 2 hr. Standard fatty acids were added to the radioactive fatty acid product of platelet fatty acid synthesis, and the individual fatty acids were collected with a stream splitter accessory and counted in a liquid scintillation counter. Other substrates and materials were prepared as described previously (3, 5) The levels of the enzymes of fatty acid synthesis depended in part on the platelet sample size as shown in Table VI . Thus, when different sized aliquots were collected, sonicated, and assayed from a pool of 5000 ml of platelet-rich plasma, higher enzyme activities were obtained (1.7-to 2.1-fold) from large batch (equivalent to 10 U) extracts than from extracts from smaller aliquots. The reason for this difference was not determined, although it seems likely that the discrepancy is due to relatively greater inactivation of platelet enzymes when smaller volumes of platelets were subjected to ultrasonic disruption. Furthermore, there were slight differences in the levels of the enzymes when platelets were collected from 50 ml of blood (Table V) compared to the small aliquot of platelets from the large platelet-rich plasma pool (Table VI CoA, coenzyme A. Samples of 50 ml of blood were used, and the total recovery of platelets from these samples is indicated. Enzymes were measured as described in Methods. * CoA, coenzyme A. Platelet-rich plasma was obtained from 10 U of blood in each experiment, and aliquots equivalent to the number of platelets contained in 50 ml of blood were removed (A), and extracts were prepared separately from this aliquot and from the remaining pooled platelet-rich plasma (B). Enzyme activities were determined on the extracts as described in Methods. Enzyme units are defined in Table V. the size of the sample processed to obtain platelet-rich plasma had some effect on enzyme recovery. It is also possible that some of this small difference was due to greater contamination of small samples with leukocytes and erythrocytes. These differences due to sample size, were not large however, and in other experiments it was shown that when blood samples of 30-100 ml were used there were no differences in enzyme activity, and that only when samples of 500 ml or greater were used were higher activities found. Furthermore, there was no correlation between enzyme activity and platelet counts when 50-ml samples in blood was used with counts ranging from 150,000/mm8 to 1,500,000/mm3.
Incorporation of acetate into fatty acids has been reported previously with extracts of human liver (13) and adipose (14) tissue; however, no evaluation of the levels of the enzymes of de novo fatty acid synthesis have been reported with human tissues. The levels of acetylCoA carboxylase and fatty acid synthetase were measured in samples of human liver obtained during surgery as shown in Table VII . The two specimens of liver obtained were histologically normal. One was from a patient who underwent cholecystectomy for chronic cholecystitis and the other patient had idiopathic thrombocytopenic purpura and underwent splenectomy. The levels of the enzymes of fatty acid synthesis in platelets from the latter patient (E.M.) are shown in Figs. 3 and 4. It is of interest that acetyl-CoA carboxylase appears to be the rate-limiting enzyme for fatty acid synthesis in liver under these conditions, with levels of 0.18 and FIGURE 4 Fatty acid synthetase activity in platelets after splenectomy. Assays were carried out as described in Methods at varying intervals after splenectomy. See Fig. 3 for detailed legend.
patients noted to deviate significantly from normal subjects were patients who had undergone splenectomy. The levels of both acetyl-CoA carboxylase and fatty acid synthetase were higher in splenectomized patients than in normal subjects as shown in Table VIII . In six splenectomized subjects the mean acetyl-CoA carboxylase level was 0.086 U/mg which varied significantly from normal subjects (P < 0.001). Similarly, the mean fatty acid synthetase level in splenectomized subjects was 0.151 U/mg which is also significantly higher than control values (P < 0.001). These six patients were from 2 months to 14 yr postsplenectomy and had no common underlying disease. Patients with Idiopathic Thrombocytopenic Purpura (ITP), Idiopathic Autoimmune Hemolytic Anemia (IAHA), Lymphoma, and Hodgkin's Disease who had not had splenectomy were studied, and these patients had normal levels of platelet fatty acid synthesizing enzymes. The change in platelet enzymes was shown to occur immediately after splenectomy by measuring the levels of these enzymes at different times after splenectomy. Three patients were studied in this manner. The first had a splenectomy for IAHA and had a normal preoperative platelet count; thus, the enzyme levels were assessed both before and after splenectomv. The other two patients studied had splenectomy for ITP and, because of low preoperative platelet counts, the first samples on these patients were obtained 1 day postsplenectomy when the platelet counts were 313,000 and 190,000. The level of acetyl-CoA carboxylase after splenectomy, as shown in Fig. 3 , rises progressively for about 7-10 days postsplenectomy when it levels off or falls slightly. This rise in enzyme level was significant (r - Samples of 50 ml of blood were used. Enzyme units are defined in Table V. + 0.86, t = 5.38, P < 0.001). Similarly, a prompt rise in fatty acid synthetase also followed splenectomy in these three patients as shown in Fig. 4 . In this instance, there is more scatter to the points but the correlation is significant (r = + 0.58, t = 2.34, P < 0.05). Glucose-6-phosphate dehydrogenase, another soluble enzyme of platelets, was also measured in these extracts, and as shown in Fig. 5 , no significant change in levels of this enzyme occurred after splenectomy (r = + 0.397, t = 1.42, P > 0.2). Similarly, lactic dehydrogenase and hexokinase activities were also measured, and neither of these enzymes was significantly increased after splenectomy. Thus, the change in the enzymes of fatty acid synthesis does not reflect a generalized increase in platelet enzymes. The levels of the enzymes of fatty acid synthesis in platelets were measured pre-and postoperatively in three patients, who underwent cholecystectomy, in order to exclude the possibility that the rises in enzyme levels were nonspecific effects relating to the surgery performed. No significant changes in either acetyl-CoA carboxylase or fatty acid synthetase occurred in these patients in the 7 days postoperatively compared to preoperative levels.
DISCUSSION
These studies have demonstrated that human platelets have all of the enzymes necessary for de novo fatty acid synthesis. Furthermore, the levels of acetyl-CoA carboxylase in platelets are similar to those found in human liver, a finding suggesting that this biosynthetic pathway is relatively active in platelets. The incorporation of acetate into intact platelets shown previously (11, 12) and also in this study suggests that the pathway functions in the intact platelet. The reason why only platelets among the formed elements of the blood retain the capacity to synthesize fatty acids is obscure, and it is difficult to relate the presence of this pathway in platelets to the known role of lipids in coagulation. Furthermore, the need for complete synthesis of fatty acids in platelets is not clear since presumably platelets are able to take up preformed fatty acids from plasma (15) .
While it appears unlikely that platelet fatty acid synthesis is important in coagulation, it is possible that the platelet fatty acid synthesizing system plays a role in coagulation rather than serving for caloric storage as the liver system. Our experiments suggest, however, that acetyl-CoA carboxylase from platelets is very similar to enzyme derived from rat liver. Thus, the requirements of the two enzymes are identical, the substrate affinities are similar, and both require citrate for activity, and are converted from a protomeric to polymeric form in the presence of citrate. The pH profile of activity is the same for the two enzymes, and both are competitively inhibited by malonyl-CoA. One difference noted is the ratio of amounts of acetyl-CoA carboxylase compared to fatty acid synthetase. In both human liver (Table  VII) and rat liver (15) , acetyl-CoA carboxylase is the rate-limiting step for fatty acid synthesis under most conditions, while in platelets it would appear that levels of the two enzymes are more nearly equal so that changes in either might affect the over-all rate of fatty acid synthesis. Also, the product of the platelet fatty acid synthetase was shown to be palmitate, the same product formed in liver. Further support for the hypothesis that the platelet fatty acid biosynthetic enzymes are similar to those from liver are studies of Hennes et al. (11) in which the pattern of acetate incorporation into platelet fatty acids was compared in normal and diabetic subjects. From Schmidt degradation of the fatty acids formed, it was suggested that de novo fatty acid synthesis was decreased in the diabetic state, a finding previously shown in livers of diabetic rats (16).
ADP had no apparent differential effect on the platelet acetyl-CoA carboxylase compared to liver enzyme and also had no effect on platelet fatty acid synthetase, a finding thus suggesting that the ADP effect on platelets is not mediated through this pathway.
The effects of splenectomy on the enzymes of platelet fatty acid synthesis are striking and suggest that the spleen may have a regulatory influence on this biosynthetic pathway in platelets. There are several possible explanations for the rise in enzyme levels after splenectomy.
The spleen may function to remove or "depit" enzymes from platelets in a manner analogous to that proposed for inclusions within erythrocytes (17) . The major difficulty with this hypothesis is that the fatty acid biosynthetic enzymes are "soluble," and thus it is difficult to understand how they would be physically removed from platelets. A second possibility is that newlyformed platelets have a higher activity of fatty acid synthesis, and that normally the spleen in some way inhibits these enzymes. A third possibility is that the spleen has some regulatory effect on the amount of enzyme synthesized in the megakaryocyte which ultimately affects platelet enzyme levels. The time course of rising activity which reaches a peak after about 1 wk would be consistent with this hypothesis. Furthermore, in the ITP patients, where presumably all of the platelets circulating 1 day postsplenectomy were newly formed, the maximum levels of enzyme were not obtained for about 1 wk, a finding suggesting that the effect of the spleen might be at some step very early in platelet formation. Another possibility is that the normal pooling of a large fraction of the total platelets in the spleen (18) 
